CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pcas SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pcas SA
21 Chemin de la Sauvegarde, Ecully Cedex
Phone: +33 169097785p:+33 169097785 ECULLY, 69134  France Ticker: PCAPCA
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Pcas SA, formerly Produits Chimiques Auxiliaires Et De Synthese SA, is a France-based company engaged in the development and manufacture of complex molecules for life sciences and specialty chemicals markets. It operates through nine production sites and two main business units, Pharma Synthesis and Fine & Specialty Chemicals. Pharma Synthesis unit specializes in active pharmaceutical ingredients (API), intermediates and building blocks, and early phase services, among others. Fine & Specialty Chemicals unit focuses on custom manufacturing and proprietary products, such as fragrance, flavor ingredients, imaging and microelectronics chemicals. The Company operates several subsidiaries, including Saint-Jean Photochimie, Societe Bearnaise de Synthese, Expansia, PCAS BioMatrix Inc, based in Canada, and PCAS Finland Oy, based in Finland, among others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2865 Cyclic organic crudes and intermediates, and organic dyes and pigments
3861 Photographic equipment and supplies
2899 Chemicals and chemical preparations, not elsewhere classified
8711 Engineering services
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer PierreLuzeau 56 3/23/2020 6/20/2017
Deputy Chief Executive Officer, Member of the Executive Committee PhilippeClavel 1/1/2020 1/1/2020
Deputy Chief Executive Officer, Member of the Executive Committee SebastienTaillemite 1/1/2018 1/1/2018
4 additional Officers and Directors records available in full report.

Business Names
Business Name
Expansia
PCA
PCAS
4 additional Business Names available in full report.

General Information
Number of Employees: 1,178 (As of 6/30/2023)
Outstanding Shares: 13,741,673 (As of 6/30/2023)
Shareholders: 1,164
Stock Exchange: EPA
Fax Number: +33 164482319


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024